The receptor for advanced glycation end products (RAGE) is another damage-associated molecular pattern (DAMP) receptor that plays a critical role in the pathogenesis of breast cancer [53] and has also been implicated in NET formation [54]. Here, AGER is linked to breast carcinoma.